Glioma: Novel considerations and treatment modalities

J F Tomera1

  • 1International Consulting Pharmacologist, Medfield, Massachusetts 02052-3127, USA.

Insights

This review explores novel treatments for aggressive glioma tumors, focusing on their invasiveness and spread within the central nervous system. It examines emerging therapies targeting glioma cells and tumor-sustaining molecules to improve patient outcomes.

Area of Science:

  • Neuro-oncology
  • Cancer Biology
  • Medical Imaging

Background:

  • Glioma tumors are highly invasive, evading conventional treatments and spreading through the central nervous system.
  • Magnetic resonance imaging (MRI) is crucial for identifying and anatomically classifying brainstem gliomas.
  • Understanding glioma cell adhesion, migration, proliferation, angiogenesis, and neurotoxin release is key to developing effective therapies.

Purpose of the Study:

  • To review novel interventions for treating aggressive glioma tumors.
  • To examine the mechanisms of glioma cell survival and spread.
  • To discuss current and emerging therapeutic strategies.

Main Methods:

  • Review of recent interventional studies on glioma treatment.
  • Analysis of mechanisms underlying glioma invasiveness and spread.
  • Discussion of targeted agents, chemotherapy, radiotherapy, and surgery.

Main Results:

  • Glioma cells exhibit unique characteristics that facilitate survival and brain invasion.
  • Novel therapies aim to target glioma cells specifically, limit cancer spread, or block tumor-sustaining molecules.
  • A range of therapeutic approaches, including targeted agents and traditional methods, are being investigated.

Conclusions:

  • Effective treatment of gliomas requires understanding their invasive nature and unique biological mechanisms.
  • Novel interventions show promise in targeting glioma cells and their microenvironment.
  • A combination of therapeutic strategies may be necessary to improve outcomes for glioma patients.

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...